GlassScriptPhysician profile
Robert G Bonillas
NPI 1598969198
$6,361.82
in general payments reported to CMS, 2019-2025
29 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $331 · 2021: $790 · 2022: $363 · 2023: $285 · 2024: $2,082 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,150 · Travel and Lodging: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,150.14 |
| Travel and Lodging | $757.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,619.31 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $935.30 | 2020-2022 | |
| Novo Nordisk INC | $421.12 | 2021-2025 | Wegovy |
| Revance Therapeutics, INC. | $384.36 | 2024-2025 | Daxxify |
| Allergan, INC. | $373.82 | 2019-2022 | |
| Medtronic, INC. | $247.91 | 2024-2025 | Intellis Adaptivestim, Interstim |
| Teva Pharmaceuticals USA, INC. | $212.67 | 2019-2022 | |
| Edwards Lifesciences Corporation | $160.82 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Impulse Dynamics (USA) INC. | $158.88 | 2025 | Optimizer |
| Pacira Pharmaceuticals Incorporated | $157.17 | 2019-2023 | Exparel |
| Madrigal Pharmaceuticals | $145.29 | 2025 | Rezdiffra |
| Stemline Therapeutics INC. | $142.23 | 2025 | Orserdu |
| Davol INC. | $136.49 | 2021 | |
| Amgen INC. | $122.15 | 2025 | Otezla |
| Inspire Medical Systems, INC. | $117.53 | 2023 | Inspire |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $115.99 | 2019 | |
| Boston Scientific Corporation | $111.49 | 2019 | |
| Abbott Laboratories | $111.02 | 2025 | Eterna |
| Astrazeneca Pharmaceuticals LP | $110.53 | 2019 | |
| Phathom Pharmaceuticals, INC. | $107.17 | 2024 | Voquezna |
| Rare Disease Therapeutics, INC. | $96.84 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $80.16 | 2020-2021 | |
| Angiodynamics, INC. | $78.25 | 2025 | Auryon Laser System 100-120 Vac |
| Galderma Laboratories, L.P. | $68.60 | 2022-2023 | |
| Penumbra, INC. | $33.76 | 2025 | Indigo System |
| Motiva USA, LLC | $30.49 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.78 | 2025 | |
| Merz North America, INC. | $27.43 | 2019 | |
| Mentor Worldwide LLC | $25.26 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bonillas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.